Organization | Institute for Molecular Medicine

Institute for Molecular Medicine Report issue

Foundation

Organization Overview

First Clinical Trial

2014

NCT03973203

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2021

Timeline

NOW

Now

Alternative names

Institute for Molecular Medicine

Active Ingredients

Drugs in Other Trials (5)

calcium carbonate (1 trial)

calcium phosphate (1 trial)

d-carnitine (1 trial)

magnesium oxide (1 trial)

niacin (2 trials)

Indications

Overview

Highest Phase: Phase 0
# of Trials: 3
# of Trial APIs: 5